Cargando…
Real-life outcomes for oral disease-modifying treatments of relapsing-remitting multiple sclerosis patients: Adherence and adverse event profiles from Marmara University
BACKGROUND/AIM: Disease-modifying treatments (DMT) are used to prevent future relapses and disability. High long-term adherence to treatment is important to achieve disease control. This study aims to investigate and compare adherence, adverse event (AE) profiles, and frequencies, main reasons for t...
Autores principales: | VURAL, Ezgi, ENGİN, Esin, SÜNTER, Gülin, AĞAN, Kadriye, GÜNAL, Dilek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388038/ https://www.ncbi.nlm.nih.gov/pubmed/37476900 http://dx.doi.org/10.55730/1300-0144.5640 |
Ejemplares similares
-
Unusual progression of an adult-onset subacute sclerosing panencephalitis (SSPE) in Turkey
por: Vural, Ezgi, et al.
Publicado: (2019) -
Acquired modification of sphingosine-1-phosphate lyase activity is not related to adrenal insufficiency
por: Sunter, Gulin, et al.
Publicado: (2018) -
Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence
por: Bayas, Antonios, et al.
Publicado: (2015) -
Seroprevalence of Q Fever in Sheep and Goats from the Marmara Region, Turkey
por: Karagul, Mustafa Sencer, et al.
Publicado: (2019) -
Medication Adherence and Healthcare Utilization in Relapsing-Remitting Multiple Sclerosis Patients Using Teriflunomide
por: Greene, Nupur, et al.
Publicado: (2022)